Clinical Case Reports (Mar 2022)
Very rare near‐haploid acute lymphoblastic leukemia resistant to immunotherapy and CAR‐T therapy in 19‐year‐old male patient
- Tomas Arpas,
- Hana Jelinkova,
- Stepan Hrabovsky,
- Martina Orsulova,
- Zuzana Vrzalova,
- Veronika Navrkalova,
- Eva Brhelova,
- Lenka Bryjova,
- Alena Bulikova,
- Eva Ondrouskova,
- Marketa Sejnohova,
- Frantisek Folber,
- Petra Sedová,
- Jiri Mayer,
- Sarka Pospisilova,
- Marie Jarosova,
- Michael Doubek
Affiliations
- Tomas Arpas
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Hana Jelinkova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Stepan Hrabovsky
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Martina Orsulova
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Zuzana Vrzalova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Veronika Navrkalova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Eva Brhelova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Lenka Bryjova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Alena Bulikova
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Eva Ondrouskova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Marketa Sejnohova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Frantisek Folber
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Petra Sedová
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Jiri Mayer
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Sarka Pospisilova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Marie Jarosova
- Center of Molecular Biology and Genetics Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- Michael Doubek
- Department of Internal Medicine, Hematology and Oncology University Hospital and Faculty of Medicine Brno Czechia
- DOI
- https://doi.org/10.1002/ccr3.5545
- Journal volume & issue
-
Vol. 10,
no. 3
pp. n/a – n/a
Abstract
Abstract Near‐haploid acute lymphoblastic leukemia is rare subgroup of the disease, which is very important due to very poor prognosis and resistance to treatment including novel monoclonal antibodies and CAR‐T therapy.
Keywords
